explore -WSS

explore

author：entertainment 2025-10-01 00:47:34 - browse：7

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

WSS

Element Biosciences CEO lays out genome sequencing strategy

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Reporting on presidential health from Reagan to Trump and Biden

Measles policy set amid Florida outbreak alarms vaccine proponents

Measles policy set amid Florida outbreak alarms vaccine proponents

Element Biosciences CEO lays out genome sequencing strategy

explore

explore

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

UnitedHealth financials solid despite Change Healthcare cyberattack

Affirmative action in medical school literally saved lives

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

In Memoriam: Notable people who died in 2023

MD Anderson's Padmanee Sharma responds to research credit suit

How to save PrEP access — and even expand it

Element Biosciences CEO lays out genome sequencing strategy

Drug repurposing or repositioning? The language matters

A new drug could help frostbite victims avoid its ravages

knowledge

MassMutual is introducing free genetic testing for members

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

New CMS data security rules will hurt Medicare, Medicaid research

Health care needs a new profession: neuroimaging counseling

As AI regulations shape up, health tech startups beg for clarity

Getting Alzheimer's drug Leqembi to patients can be a challenge

focus

explore

focus

leisure time